pegtarviliase

Faced with rocky interim data for rare disease drug, Aeglea lays off more staff and seeks exit route
Fierce Biotech
Wed, 04/12/23 - 11:45 am
Aeglea BioTherapeutics
layoffs
pegtarviliase